share_log

Insider Sale: Director at $VCYT (VCYT) Sells 5,309 Shares

Insider Sale: Director at $VCYT (VCYT) Sells 5,309 Shares

內部出售:$VCYt (VCYT) 的董事售出5,309股
Quiver Quantitative ·  01/07 06:34

KARIN EASTHAM, a director at $VCYT ($VCYT), sold 5,309 shares of the company on 01-02-2025. We received data on the trade from a recent SEC filing. This was a sale of approximately 18.6% of their shares. Following this trade, they now own 23,188 shares of $VCYT stock.

KARIN EASTHAm, 一名在 $VCYt ($VCYT) 的董事,於2025年01月02日出售了5,309股該公司的股票。我們從最近的SEC備案中收到了有關此次交易的數據。這次銷售約佔他們持股的18.6%。在這次交易後,他們現擁有$VCYt股票的23,188股。

$VCYT Insider Trading Activity

$VCYt 內部人交易活動

$VCYT insiders have traded $VCYT stock on the open market 34 times in the past 6 months. Of those trades, 0 have been purchases and 34 have been sales.

$VCYt 的內部人在過去6個月裏在公開市場上交易$VCYt股票34次。其中,0次爲購買,34次爲銷售。

Here's a breakdown of recent trading of $VCYT stock by insiders over the last 6 months:

以下是過去6個月內部人對$VCYt股票最近交易的詳細信息:

  • KARIN EASTHAM has traded it 6 times. They made 0 purchases and 6 sales, selling 32,231 shares.
  • MARC STAPLEY (Chief Executive Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 5,590 shares.
  • PHILLIP G. FEBBO (Chief Scientific & Med Officer) sold 3,934 shares.
  • ANNIE MCGUIRE (SVP, General Counsel) sold 18,699 shares.
  • JOHN LEITE (Chief Commercial Officer-CLIA) has traded it 3 times. They made 0 purchases and 3 sales, selling 7,806 shares.
  • REBECCA CHAMBERS (Chief Financial Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 22,275 shares.
  • JONATHAN WYGANT (VP, Chief Accounting Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 5,988 shares.
  • ROBERT S EPSTEIN sold 15,000 shares.
  • EVAN/ FA JONES has traded it 12 times. They made 0 purchases and 12 sales, selling 59,904 shares.
  • JENS HOLSTEIN has traded it 4 times. They made 0 purchases and 4 sales, selling 10,000 shares.
  • KARIN EASTHAm 交易了6次。他們進行了0次購買和6次銷售,出售了32,231股。
  • MARC STAPLEY (首席執行官) 交易了2次。他們進行了0次購買和2次銷售,出售了5,590股。
  • PHILLIP G. FEBBO (首席科學&醫療官) 出售了3,934股。
  • ANNIE MCGUIRE (高級副總裁,法律顧問) 出售了18,699股。
  • 約翰·萊特(首席商業官-CLIA)交易了3次。他們沒有購買,銷售了7,806股。
  • 麗貝卡·查姆斯(財務長)交易了2次。他們沒有購買,銷售了22,275股。
  • 喬納森·維根(副總裁,首席會計官)交易了2次。他們沒有購買,銷售了5,988股。
  • 羅伯特·S·愛潑斯坦出售了15,000股。
  • 埃文/法·瓊斯交易了12次。他們沒有購買,銷售了59,904股。
  • 延斯·霍爾斯坦交易了4次。他們沒有購買,銷售了10,000股。

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

要跟蹤內部交易,請查看Quiver Quantitative的內部交易儀表。

$VCYT Hedge Fund Activity

$VCYt 對沖基金活動

We have seen 156 institutional investors add shares of $VCYT stock to their portfolio, and 109 decrease their positions in their most recent quarter.

我們看到156家機構投資者在最近一個季度增加了$VCYt股票的持股,109家機構減少了其持股。

Here are some of the largest recent moves:

以下是最近的一些重大變動:

  • WELLINGTON MANAGEMENT GROUP LLP removed 2,643,340 shares (-38.4%) from their portfolio in Q3 2024
  • ARTISAN PARTNERS LIMITED PARTNERSHIP added 1,959,123 shares (+63.9%) to their portfolio in Q3 2024
  • ARK INVESTMENT MANAGEMENT LLC removed 1,888,552 shares (-27.7%) from their portfolio in Q3 2024
  • MACQUARIE GROUP LTD added 711,362 shares (+inf%) to their portfolio in Q3 2024
  • CHAMPLAIN INVESTMENT PARTNERS, LLC removed 636,190 shares (-20.1%) from their portfolio in Q3 2024
  • FIERA CAPITAL CORP removed 625,536 shares (-100.0%) from their portfolio in Q3 2024
  • POINT72 ASSET MANAGEMENT, L.P. removed 566,634 shares (-100.0%) from their portfolio in Q3 2024
  • WELLINGTON MANAGEMENt GROUP LLP在2024年第三季度從其投資組合中移除了2,643,340股(-38.4%)。
  • ARTISAN PARTNERS LIMITED PARTNERSHIP在2024年第三季度向其投資組合中增加了1,959,123股(+63.9%)。
  • ARK INVESTMENt MANAGEMENt LLC在2024年第三季度從其投資組合中移除了1,888,552股(-27.7%)。
  • MACQUARIE GROUP LTD在2024年第三季度向其投資組合中增加了711,362股(+inf%)。
  • CHAMPLAIN INVESTMENt PARTNERS, LLC在2024年第三季度從其投資組合中移除了636,190股(-20.1%)。
  • Fiera Capital CORP在2024年第三季度從其投資組合中移除了625,536股(-100.0%)
  • POINT72資產管理公司在2024年第三季度從其投資組合中移除了566,634股(-100.0%)

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

要跟蹤對沖基金的股票投資組合,請查看Quiver Quantitative的機構持有情況儀表。


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

本文不是金融建議。有關更多信息,請參閱Quiver Quantitative的免責聲明。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論